Shen, S., Myers, S., Polidorio, N., Bromberg, M., Chen, Y., Tan, R., Mai, N., Abuhadra, N., Traina, T. A., Downs-Canner, S., Iyengar, N. M. (2025). Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e12616